Anti-ENPP5/ NPP-5/ NPP5 monoclonal antibody

Anti-ENPP5/ NPP-5/ NPP5 antibody for FACS & in-vivo assay

Target products collectionGo to ENPP5/ENPP5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0411-Ab-1/ GM-Tg-hg-MP0411-Ab-2Anti-Human ENPP5 monoclonal antibodyHuman
GM-Tg-rg-MP0411-Ab-1/ GM-Tg-rg-MP0411-Ab-2Anti-Rat ENPP5 monoclonal antibodyRat
GM-Tg-mg-MP0411-Ab-1/ GM-Tg-mg-MP0411-Ab-2Anti-Mouse ENPP5 monoclonal antibodyMouse
GM-Tg-cynog-MP0411-Ab-1/ GM-Tg-cynog-MP0411-Ab-2Anti-Cynomolgus/ Rhesus macaque ENPP5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0411-Ab-1/ GM-Tg-felg-MP0411-Ab-2Anti-Feline ENPP5 monoclonal antibodyFeline
GM-Tg-cang-MP0411-Ab-1/ GM-Tg-cang-MP0411-Ab-2Anti-Canine ENPP5 monoclonal antibodyCanine
GM-Tg-bovg-MP0411-Ab-1/ GM-Tg-bovg-MP0411-Ab-2Anti-Bovine ENPP5 monoclonal antibodyBovine
GM-Tg-equg-MP0411-Ab-1/ GM-Tg-equg-MP0411-Ab-2Anti-Equine ENPP5 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0411-Ab-1/ GM-Tg-hg-MP0411-Ab-2; GM-Tg-rg-MP0411-Ab-1/ GM-Tg-rg-MP0411-Ab-2;
GM-Tg-mg-MP0411-Ab-1/ GM-Tg-mg-MP0411-Ab-2; GM-Tg-cynog-MP0411-Ab-1/ GM-Tg-cynog-MP0411-Ab-2;
GM-Tg-felg-MP0411-Ab-1/ GM-Tg-felg-MP0411-Ab-2; GM-Tg-cang-MP0411-Ab-1/ GM-Tg-cang-MP0411-Ab-2;
GM-Tg-bovg-MP0411-Ab-1/ GM-Tg-bovg-MP0411-Ab-2; GM-Tg-equg-MP0411-Ab-1/ GM-Tg-equg-MP0411-Ab-2
Products NameAnti-ENPP5 monoclonal antibody
Formatmab
Target NameENPP5
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ENPP5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ENPP5/ NPP-5/ NPP5 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0411
    Target NameENPP5
    Gene ID59084,83965,316249,706238,481824,101099462,512304,100055708
    Gene Symbol and SynonymsD17Abb1e,E-NPP 5,ENPP5,NPP-5,NPP5
    Uniprot AccessionQ9UJA9,P84039
    Uniprot Entry NameENPP5_HUMAN,ENPP5_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000112796
    Target ClassificationN/A

    The target: ENPP5, gene name: ENPP5, also named as NPP-5, NPP5. This gene encodes a type-I transmembrane glycoprotein. Studies in rat suggest the encoded protein may play a role in neuronal cell communications. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.